<DOC>
	<DOCNO>NCT01199497</DOCNO>
	<brief_summary>Multicenter clinical trial , phase III , control active medicine , double-blind , randomize , enroll 208 subject , 12 year old , suffer acute inflammation upper airway characterize non-productive cough , daytime/nighttime , duration least 3 5 consecutive day ( without systemic/topic use medication period ) follow nasal congestion , without associate nasal symptom ( sneeze , runny nose , nasal itch and/or mouth breathing ) . The subject allocate 2 parallel group , receive medicine study , accord randomization .</brief_summary>
	<brief_title>Study Evaluate Efficacy Safety Fixed Dose Combination Diphenhydramine + Pseudoephedrine + Dropropizine Control Cough Relief Nasal Symptoms , Suffering From Non-productive Cough Acute Rhinitis</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Cough</mesh_term>
	<mesh_term>Common Cold</mesh_term>
	<mesh_term>Diphenhydramine</mesh_term>
	<mesh_term>Promethazine</mesh_term>
	<mesh_term>Ephedrine</mesh_term>
	<mesh_term>Pseudoephedrine</mesh_term>
	<mesh_term>Dipropizine</mesh_term>
	<criteria>1 . Patients 12 year old , sex ; 2 . Clinical condition compatible acute rhinitis accompany nasal congestion ; 3 . Nonproductive cough , daytime and/or nighttime least 3 5 consecutive day duration ; 4 . Score great equal 3 point cough severity score ( As per item 4.1.2 ) ; 5 . Score great equal 2 point nasal congestion severity score ( As per item 4.1.3 ) ; 6 . If necessary , ICF sign parent/representant , case patient 18 year old , signature ; 7 . Patient and/or representant capacity , accord investigator evaluation , compliance treatment protocol requirement , fulfil regular visit ; 1 . Nonproductive cough purulent smear , fever ( axilar temperature superior 37,8°C/100°F ) , purulent runny nose sign symptom bacteria infection upper low airway 7 day screening/randomization visit ; 2 . Septal deviation level III ( region nasal cavity ) and/or nasal polyps determinant condition nasal congestion ; 3 . Previous diagnosis asthma ; 4 . Female patient positive bHCG ; 5 . Patients treatment chronic allergy ; 6 . Presence purulent mucupurulent secretion , nasal vault mal formation ( cleft lip cleave nasolabial correct ) nasal vestibule ; 7 . Current use systemic antibiotic reason ; 8 . Use prohibit medicine within prescribed period V0 show item 9.3 protocol ; 9 . Participation last one year clinical protocol ; 10 . Any psychiatric disease , include major depression ; 11 . Presence mental retardation cause ; 12 . Diagnosis renal hepatic failure ; 13 . History hypersensitivity component study drug ; 14 . Relatives sponsor´s study site´s employee ; 15 . Current evidence clinically significant disease : hematopoietic , gastrointestinal , cardiovascular , hepatic , renal , neurological , endocrine , psychiatric , autoimmune , pulmonary , another disease block patient participation ; 16 . Patient parent/representant history lack compliance treatment previous treatment protocol ; 17 . Any finding clinical observation ( anamnesis physical exam ) laboratory abnormality ( eg , blood glucose , blood count ) , disease ( example , liver , cardiovascular system , lung ) therapy , opinion investigator , may endanger patient interfere endpoint study .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>cough , acute rhinitis , nasal congestion , common cold , nasal symptom , child .</keyword>
	<keyword>Nasal congestion non-productive cough , without associate nasal extranasal symptom .</keyword>
</DOC>